Results 81 to 90 of about 51,322 (300)

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis

Frontiers in Medicine, 2022
BackgroundBullous pemphigoid (BP) is the most common autoimmune-blistering disease, clinically characterized by erythematous urticarial plaques, blisters, and intense pruritus, induced by autoantibodies against two proteins of the dermo-epidermal ...
Francesco Moro, Francesco Moro, Feliciana Mariotti, Anna Pira, Naomi De Luca, Biagio Didona, Gianluca Pagnanelli, Giovanni Di Zenzo   +7 more
doaj   +1 more source

Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Mucous membrane pemphigoid (MMP) has a broad range of clinical manifestations, from relatively benign self‐limiting oral lesions to significant scarring (cicatrizing) of the oral, nasal and ocular tissues with severe functional impairment and morbidity.
Bronte Jeffrey, Mark Schifter, Elizabeth Arena, Emily Sullivan, Stephanie Rose, David Joo, David Campbell, Suzanne Culican, David McDonald, Ming Wei Lin   +9 more
wiley   +1 more source

Bullous pemphigoid in younger adults: three case reports [PDF]

, 2011
O penfigoide bolhoso é uma dermatose bolhosa autoimune subepidérmica, mais comumente observada na população idosa (acima dos 70 anos). Autoanticorpos são formados contra antígenos específicos da zona de membrana basal: BP180 e BP230 (proteínas do ...
AOKI, Valéria, SANCHEZ, Ana Paula Galli, TEBCHERANI, Antônio José, XAVIER, Tamar Alencar, ZANELLA, Roberta Richter   +4 more
core   +4 more sources

Metronidazole-Induced Bullous Pemphigoid: A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2015
Bullous pemphigoid is an autoimmune cutaneous blistering disorder, the exact pathogenesis of which is still not fully elucidated. Drug-induced bullous pemphigoid eruptions are rare but have been reported earlier with the use of frusemide, psoralens ...
Saibal Moitra, Sukanta Sen, Indranil Banerjee, Ayan Sikder, Prasanta Das   +4 more
doaj   +1 more source

Case Report: Variety of Target Antigens During 1 Year Follow-Up of a Patient Initially Diagnosed With Bullous Pemphigoid

Frontiers in Immunology, 2022
Autoimmune bullous diseases (AIBDs), presenting cutaneous and/or mucosal bullous lesions, are classified into pemphigus and pemphigoid diseases. A longtime observation for complicated AIBD cases is rarely reported.
Hua Qian, Zhijun Zhou, Luhuai Shi, Huicheng Li, Weijun Liu, Yong Ai, Yangmin Gao, Suying Feng, Takashi Hashimoto, Xiaoguang Li   +9 more
doaj   +1 more source

IgE autoantibodies in serum and skin of non‐bullous and bullous pemphigoid patients

Journal of the European Academy of Dermatology and Venereology, 2020
Non‐bullous pemphigoid (NBP) is a pemphigoid variant which frequently resembles other pruritic skin diseases. In contrast with bullous pemphigoid (BP), blisters are absent.
A. Lamberts, N. Kotnik, G. Diercks, J. Meijer, G. Zenzo, H. Pas, M. Jonkman, B. Gibbs, U. Raap, B. Horváth   +9 more
semanticscholar   +1 more source

The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study [PDF]

, 2012
BACKGROUND: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool is intended to be used in the design phase of trials to help investigative teams design trials in-line with their purpose.
Andrew J Nunn, Anna Sandell, Daniel J Bratton, DJ Bratton, DL Riddle, Fenella Wojnarowska, G Tosh, Gudula Kirtschig, Hywel C Williams, KE Thorpe, M Zwarenstein, P Joly, P Joly, RB D'Agostino, RE Glasgow, T Koppenaal   +15 more
core   +2 more sources

Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine

Diagnostics
Background: Bullous pemphigoid is an autoimmune bullous disease that frequently affects a large skin surface area, but it can also present in localized areas.
Emi Mashima, Natsuko Saito-Sasaki, Yu Sawada   +2 more
doaj   +1 more source

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl, Henning Schliephake, Simon Storgård Jensen   +2 more
wiley   +1 more source

Prevalence and treatment patterns of psoriatic arthritis in the UK.

, 2012
OBJECTIVES: The objectives of this study were to determine the prevalence of PsA in The Health Improvement Network (THIN), a large population-based medical records database in the UK, to examine factors associated with prevalent PsA among patients with ...
A. Ogdie, A. Troxel, Alamanos, Bateman, Chisholm, D. Shin, de Lusignan, Elkayam, Gladman, Gladman, H. Choi, Hollowell, J. M. Gelfand, K. Haynes, Khan, Langham, Lewis, Lewis, Love, Madland, N. N. Mehta, N. Seminara, NIGROVIC, Ogdie, Reich, S. Langan, SCARPA, Seminara, Setty, Shbeeb, Soltani-Arabshahi, T. Love, Taylor, Zachariae   +33 more
core   +1 more source